RESULTS
From March 14, 2020 to May 14, 2020, we evaluated 82 cases who consulted the adult hematology unit. The median age of the patients was 49,5 (18-93). Forty-six (56,1%) of the patients were female and 36 of the patients (43,9%) were males. The number of the consultation requested from outpatients was 46 (56,1%), while the inpatients were 36 (43,9%). The clinic that requested the most consultation was gynecology with 17 of patients (20,7%). Distribution of the clinics requested a consultation is listed in Table 1.
Eight patients were suspected with COVID-19 because of clinical signs, such as fever, cough and headache. Only two of these patients had COVID-positive according to PCR results. The frequency of suspicion of the COVID-19 was statistically significantly higher in patients with previously hematological diagnosed and also in consultation requested from inpatients (p=0,018 and p=0,019, respectively). Table 2 shows distribution associated with suspected COVID-19 patients according to features of the hematological disease and outpatient or inpatient.
Seven of the patients previously hematologic diagnosed were Hodgkin’s lymphoma, chronic lymphocytic leukemia (CLL), myelodysplastic syndrome (MDS), idiopathic thrombocytopenic purpura (ITP), multiple myeloma, Bernard- Soulier syndrome and hereditary spherocytosis with one patient in each of them. In the other 75 patients, any clinical pathologic features were not found in 11 patients and diagnostic evaluation had not been finished yet in 12 patients. The most common diagnosis was drug-related cytopenia with 11 patients (20,4%) of the 54 patients. Distribution of diagnoses is presented in Table 3. The less common diagnoses were presented like “the other” with one patient each of the diagnoses. In Table 3, diagnosis of Budd-Chiari syndrome, portal ven thrombosis, retinal ven thrombosis and hereditary thrombophilia were entitled under the upside of “thrombosis”.